MCTS1 and cancer: Taxol, a mitotic inhibitor of cancer therapy [44], was treated cells for 3 days and the MCT-1 knockdown cells (MCT-1 shRNA) exhibited a higher susceptibility to Taxol that the apoptotic effect was much increased compared to the control cells (mock) (Fig. 4A).